Effortlessly accelerate label creation, review, and translation, reducing time-to-market and boosting productivity.
Enhance operational compliance and data integrity by replacing error-prone manual processes.
ComplianceAuthor AI® works with the systems that support clinical labeling so teams can improve label creation, translation, review, and printing without disrupting the broader process.
Author, review, and manage clinical labels faster while reducing manual steps, eliminating rework, and cutting labeling timelines from four weeks to four days.
Access your in-progress
and completed clinical
labels with associated KPIs.
Automatically generate labels with the required phrases, translations, and study-specific content for each use case.
Apply approved regulatory and business rules to generate more accurate, complete, and compliant labels with less manual interpretation.
Streamline the way your team creates and collaborates on clinical label components with AI-powered features, advanced tools, and familiar integrations that help you work faster and maintain compliance.
Clinical labeling refers to the creation of labels for investigational products used in clinical trials. These labels must include study-specific details, regulatory information, and country-specific requirements to ensure patient safety and compliance. Platforms like ComplianceAuthor AI® help standardize and automate this process using structured, approved content.
Most clinical trial labels are still created through a manual process using a Master English Label Text (MELT), Excel sheets, and copy-and-paste work. Teams create the MELT first, then repeat the process for each country label by applying translations and checking country-specific requirements one by one. This takes time, creates rework, and increases the risk of error.
ComplianceAuthor AI® digitizes that process by allowing authors to create the MELT once, then use approved phrases, translations, and country-specific business rules to automate the generation of country labels. Instead of manually rebuilding each version, teams can work from approved content and let the system do the rest.
MELT, or Master English Label Text, is the base English label content used to create clinical trial labels for different countries and languages. Teams typically start with the MELT, then adapt it for each market by applying translations and country-specific requirements.
Reducing clinical labeling timelines requires eliminating manual steps like copy-pasting, reformatting, and repeated reviews. With ComplianceAuthor AI®, teams can move from MELT to fully assembled, country-specific labels in one click, reducing timelines from up to four weeks to as little as four days.
The biggest challenges in clinical labeling usually come from manual processes, country-specific complexity, and the risk of error. Teams often have to manage a Master English Label Text (MELT), apply translations, check country-specific requirements, and recreate labels across markets using spreadsheets, copy-paste work, and repeated reviews. That slows timelines, increases rework, and creates compliance risk.
ComplianceAuthor AI® helps address these challenges by digitizing approved phrases, translations, and business rules so teams can generate country-specific labels faster, with less manual effort and more control.
Compliance in clinical trial labeling depends on using approved content, applying country-specific requirements correctly, and maintaining traceability across every label created. ComplianceAuthor AI® helps enforce that process by using approved phrases, translations, and business rules to generate labels more consistently, with the control and traceability needed for audit readiness.
Country-specific clinical labels are generated by starting with the Master English Label Text (MELT), then applying approved phrases, translations, study parameters, and country-specific requirements for each market. ComplianceAuthor AI® automates that process so teams can generate country labels faster, with less manual work and more confidence that each version is built from approved content and is submission-ready.
Translations are a critical part of clinical labeling, especially for global trials. ComplianceAuthor AI® helps teams digitize and work from approved phrases and existing translations so they can reduce copy-paste work, reuse what has already been approved, and limit how much new translation is needed for each country label.
When new translations are required, teams can manage them more efficiently while keeping labels aligned and consistent across markets.
Errors in clinical labeling are often caused by manual processes, copy-paste work, inconsistent interpretation, and the challenge of applying translations and country-specific requirements correctly. ComplianceAuthor AI® helps reduce those errors by using approved phrases, translations, and business rules to automate label generation and prevent the wrong content from being applied.
Schedule a demo today to see how ComplianceAuthor AI® integrates with your RIM systems, supports production-scale labeling, and streamlines your workflows
